Auxilium Pharmaceuticals, Inc.’s (AUXL) share price has entered into oversold territory with a stochastic value of 8.6595. The Zacks Consensus Estimate on the company’s loss for December 2012 decreased by 20 cents over the past month to meet the break even point. Auxilium Pharmaceuticals, Inc. is a Zacks #2 Rank (“Buy”) company.
AUXILIUM PHARMA (AUXL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.